Old National Bancorp Glaukos Corp Transaction History

Old National Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$73.06 - $97.7 $210,705 - $281,766	-2,884 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$70.43 - $97.42 $74,514 - $103,070	-1,058 Reduced 26.84%	2,884 $242,000
Q4 2020 Jan 19, 2021	SELL	$48.9 - $75.26 $15,110 - $23,255	-309 Reduced 7.27%	3,942 $297,000
Q3 2020 Oct 29, 2020	BUY	$37.23 - $50.97 $158,264 - $216,673	4,251 New	4,251 $211,000
Q2 2019 Jul 15, 2019	SELL	$63.59 - $78.71 $203,106 - $251,399	-3,194 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$50.75 - $80.54 $162,095 - $257,244	3,194 New	3,194 $250,000
Q4 2018 Jan 31, 2019	SELL	$52.18 - $67.93 $350,493 - $456,285	-6,717 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$38.13 - $68.37 $74,582 - $133,731	-1,956 Reduced 22.55%	6,717 $436,000
Q2 2018 Jul 26, 2018	BUY	$27.62 - $44.51 $239,548 - $386,035	8,673 New	8,673 $352,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.47B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.